GUEST COLUMNISTS

PHARMA OUTSOURCING WHITE PAPERS

  • How To Avoid High Potency API Contamination

    To ensure that employee exposures are kept within accepted limits and protect the environment while containing costs, pharmaceutical companies and their contract partners who manufacture and handle high containment compounds must carefully select equipment, outline processes and procedures, and deploy appropriate containment technologies. Having standards in place for engineering controls is the first line of defense against harm from cross contamination or exposure to the patient, manufacturing employees, or the environment when working with HPAPIs.In this paper learn how to determine exposure potential and select the correct equipment and technology.

Louis2019

COVID-19 AND YOUR SUPPLY CHAINS

The Latest Analysis And Advice From Outsourced Pharma

COVID-19 AND YOUR SUPPLY CHAINS: ANALYSIS AND ADVICE FROM OUTSOURCED PHARMA

COVID-19 And Your Supply Chains: Analysis And Advice From Outsourced Pharma


The coronavirus pandemic has tossed together your drug development and manufacturing supply chains with a worldwide health and health-care challenge, national security concerns, and international and domestic politics. Outsourced Pharma Chief Editor Louis Garguilo has covered this convergence from the very beginning of the outbreak. This collection of his editorials and podcast will help you to think through your outsourcing strategy in the face of the outbreak of COVID-19, and offers some keen analysis and best practices. He suggests biotech and pharma companies take this moment in time to deeply reconsider geographic and other supply-chain risks to enhance decisions for maintaining the most reliable source of drugs and vaccines, and to openly ask and answer difficult questions. Download the eBook now.

More Content Collections

OUTSOURCING EVENTS